CV Sciences News and Activities

CV Sciences is a company listed under the stock ticker CVSI (US).

View the org chart displaying its 13 main executives

Most searched biographies at CV Sciences

• Joseph Dowling, Chief Executive Officer and Chief Financial Officer
• Bill Mccorkle, Director
• Jamie Corroon, Director

Create your alert
to follow the executive moves at CV Sciences.

CV Sciences has 2,428 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (posted on July 15 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by CV Sciences

• CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs
• CV Sciences, Inc. Reports Third Quarter 2024 Financial Results
• CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024
• CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements
• CV Sciences, Inc. Reports Second Quarter 2024 Financial Results
• Press Releases
• CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024
• CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024
• CV Sciences, Inc. Reports First Quarter 2024 Financial Results
• CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER
• View more press releases Close

Social media about CV Sciences

• CV Sciences on Wikipedia, Google News & Yahoo Finance
• CV Sciences on LinkedIn, X (Twitter) & YouTube